Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy

Marinos C. Dalakas, Goran Rakocevic, Mohammad Salajegheh, James M. Dambrosia, Angelika F. Hahn, Raghavan Raju, Beverly McElroy

Research output: Contribution to journal › Article › peer-review